216 related articles for article (PubMed ID: 22837027)
1. Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?
Harenberg J; Marx S; Wehling M
Thromb Haemost; 2012 Sep; 108(3):407-9. PubMed ID: 22837027
[No Abstract] [Full Text] [Related]
2. Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.
Skjøth F; Larsen TB; Rasmussen LH
Thromb Haemost; 2012 Sep; 108(3):405-6. PubMed ID: 22782445
[No Abstract] [Full Text] [Related]
3. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
4. New oral anticoagulant in atrial fibrillation: are they comparable?
Kalodiki E; Lewis B; Fareed J
Int Angiol; 2012 Aug; 31(4):307-9. PubMed ID: 22801395
[No Abstract] [Full Text] [Related]
5. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Ahrens I; Lip GY; Peter K
Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
[No Abstract] [Full Text] [Related]
6. [New anticoagulants in patients with atrial fibrillation].
Diener HC; Weber R
MMW Fortschr Med; 2013 May; 155(8):55-6, 58. PubMed ID: 24437140
[No Abstract] [Full Text] [Related]
7. [Stroke risk--atrial fibrillation].
Dabitz R; Ochs G
MMW Fortschr Med; 2012 Nov; 154(19):53-6. PubMed ID: 23173288
[No Abstract] [Full Text] [Related]
8. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
9. Novel anticoagulants eliminate the need for left atrial appendage exclusion devices.
Ezekowitz MD; Kent AP
Circulation; 2014 Oct; 130(17):1505-14. PubMed ID: 25332278
[No Abstract] [Full Text] [Related]
10. [Structured care for patients with new oral anticoagulants. Nursing based care of adults with atrial fibrillation].
Al-Khalili F; Lindström C
Lakartidningen; 2014 Oct 1-7; 111(40):1720-2. PubMed ID: 25759883
[No Abstract] [Full Text] [Related]
11. Defining non-valvular atrial fibrillation while selecting anticoagulation therapy.
Garg P; Ripley DP
Br J Hosp Med (Lond); 2015 Feb; 76(2):66-7. PubMed ID: 25671468
[No Abstract] [Full Text] [Related]
12. [Differential therapy with the new anticoagulants, 5].
Stiefelhagen P
MMW Fortschr Med; 2013 May; 155(9):20. PubMed ID: 23951642
[No Abstract] [Full Text] [Related]
13. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
14. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
15. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
Lane DA; Wood K
Circulation; 2015 Apr; 131(16):e412-5. PubMed ID: 25901074
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
[TBL] [Abstract][Full Text] [Related]
17. New oral anticoagulants in the management of venous thromboembolism: a major advance?
Sciascia S; Hunt BJ
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):487-8. PubMed ID: 25150440
[No Abstract] [Full Text] [Related]
18. ["Xa-tra-xa": opportunities and open questions about new anticoagulants].
Beer JH
Praxis (Bern 1994); 2011 Aug; 100(16):947. PubMed ID: 21910293
[No Abstract] [Full Text] [Related]
19. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
20. New agents to prevent strokes in nonvalvular atrial fibrillation.
Putney D; Pratt C
Methodist Debakey Cardiovasc J; 2012; 8(3):44-6. PubMed ID: 23227289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]